Health Tidings Mergers & AcquisitionsHenlius, Amberstone Develop Tumor-Activated TCEs for Solid Tumors Henlius, Amberstone Develop Tumor-Activated TCEs for Solid Tumors Read Post »
Health Tidings Mergers & AcquisitionsAtavistik Bio, Roche Partner on Allosteric CVRM Drugs Atavistik Bio, Roche Partner on Allosteric CVRM Drugs Read Post »
Health Tidings Mergers & AcquisitionsLexeo Expands Friedreich Ataxia Pipeline With Mantle Acquisition Lexeo Expands Friedreich Ataxia Pipeline With Mantle Acquisition Read Post »
Health Tidings Mergers & AcquisitionsEnvisagenics, Boehringer Partner on RNA Splicing Cancer Targets Envisagenics, Boehringer Partner on RNA Splicing Cancer Targets Read Post »
Health Tidings Mergers & AcquisitionsAbbVie and Iambic Partner to Accelerate AI-Driven Small-Molecule Drug Disco... AbbVie and Iambic Partner to Accelerate AI-Driven Small-Molecule Drug Disco... Read Post »
Health Tidings Mergers & AcquisitionsTelix to Acquire ITM in $1.65 Billion Radiopharmaceutical Deal Telix to Acquire ITM in $1.65 Billion Radiopharmaceutical Deal Read Post »
Mergers & Acquisitions1ST-104 Parkinson’s Drug Licensed by SK Biopharmaceuticals 1ST-104 Parkinson’s Drug Licensed by SK Biopharmaceuticals Read Post »
Health Tidings Mergers & AcquisitionsRoche, Dualitas Launch Bispecific Antibody Discovery Deal Roche, Dualitas Launch Bispecific Antibody Discovery Deal Read Post »
Health Tidings Mergers & AcquisitionsLisata Acquires Marea, Raises $225M for Cardioendocrine Drug Development Lisata Acquires Marea, Raises $225M for Cardioendocrine Drug Development Read Post »
Health Tidings Mergers & AcquisitionsNovo Nordisk and Anthropic Partner to Accelerate AI-Driven Drug Discovery Novo Nordisk and Anthropic Partner to Accelerate AI-Driven Drug Discovery Read Post »
Health Tidings Mergers & AcquisitionsGSK to Acquire Chimagen’s Trispecific T-Cell Engager for Multiple Myeloma GSK to Acquire Chimagen’s Trispecific T-Cell Engager for Multiple Myeloma Read Post »
Health Tidings Mergers & AcquisitionsHUTCHMED Licenses KRAS-EGFR Therapy to GSK in $1.3 Billion Deal HUTCHMED Licenses KRAS-EGFR Therapy to GSK in $1.3 Billion Deal Read Post »
Health Tidings Mergers & AcquisitionsDualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... DualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... Read Post »
Health Tidings Mergers & AcquisitionsMcKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding C... McKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding C... Read Post »
Health Tidings Mergers & AcquisitionsHanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate H... Hanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate H... Read Post »
Health Tidings Mergers & AcquisitionsWerewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Werewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Chai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Read Post »
Health Tidings Mergers & AcquisitionsTolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Tolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Read Post »
Health Tidings Mergers & AcquisitionsFulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Fulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC IDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC Read Post »
Health Tidings Mergers & AcquisitionsChugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Chugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Read Post »
Health Tidings Mergers & AcquisitionsBioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... BioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... Read Post »
Health Tidings Mergers & AcquisitionsLEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... LEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... Read Post »
Mergers & AcquisitionsOmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... OmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... Read Post »
Mergers & AcquisitionsZealand Pharma Sells Rusfertide Royalty Rights to Royalty Pharma for $100 M... Zealand Pharma Sells Rusfertide Royalty Rights to Royalty Pharma for $100 M... Read Post »
Health Tidings Mergers & AcquisitionsSentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Sentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Read Post »
Mergers & AcquisitionsJazz Pharmaceuticals to Acquire Actio Biosciences to Expand Rare Epilepsy P... Jazz Pharmaceuticals to Acquire Actio Biosciences to Expand Rare Epilepsy P... Read Post »
Health Tidings Mergers & AcquisitionsSobi enters strategic partnership with Innate Pharma to license lacutamab i... Sobi enters strategic partnership with Innate Pharma to license lacutamab i... Read Post »
Health Tidings Mergers & AcquisitionsBeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia BeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia Read Post »
Health Tidings Mergers & AcquisitionsEvotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Evotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Read Post »
Health Tidings Mergers & AcquisitionsOno and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Ono and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Read Post »
Manufacturing Mergers & AcquisitionsFujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Fujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Read Post »
Health Tidings Mergers & AcquisitionsEvexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Evexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Read Post »
Clinical Trials Mergers & AcquisitionsAmplia and Lilly Partner to Advance Narmafotinib Plus Olomorasib for KRAS G... Amplia and Lilly Partner to Advance Narmafotinib Plus Olomorasib for KRAS G... Read Post »
Health Tidings Mergers & AcquisitionsAbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers AbCellera, Vertex Sign Deal to Develop Autoimmune T-Cell Engagers Read Post »
Health Tidings Mergers & AcquisitionsRelation, GSK Partner in $110M AI Drug Discovery Collaboration Relation, GSK Partner in $110M AI Drug Discovery Collaboration Read Post »
Mergers & AcquisitionsJohnson & Johnson Partners with Sail Biomedicines for In Vivo CAR-T The... Johnson & Johnson Partners with Sail Biomedicines for In Vivo CAR-T The... Read Post »
Mergers & AcquisitionsCSL Reports Positive Phase 3b Results for ANDEMBRY in Children With HAE CSL Reports Positive Phase 3b Results for ANDEMBRY in Children With HAE Read Post »
Mergers & AcquisitionsEntera Bio Positions EB613 for Phase 3 Osteoporosis Studies Entera Bio Positions EB613 for Phase 3 Osteoporosis Studies Read Post »
Health Tidings Mergers & AcquisitionsBioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... BioMarin, n-Lorem Advance First Mutation-Targeted Therapy for Newly Discove... Read Post »
Health Tidings Mergers & Acquisitionsargenx Adds First-in-Class FB102 Through $2.2B Forte Biosciences Acquisitio... argenx Adds First-in-Class FB102 Through $2.2B Forte Biosciences Acquisitio... Read Post »
Health Tidings Mergers & AcquisitionsYarrow Bioscience Initiates Phase 2 Trial of Anti-TSHR Antibody YB-101 for ... Yarrow Bioscience Initiates Phase 2 Trial of Anti-TSHR Antibody YB-101 for ... Read Post »
Mergers & AcquisitionsArcus and Summit Launch Casdatifan–Ivonescimab Trial in Metastatic Kidney... Arcus and Summit Launch Casdatifan–Ivonescimab Trial in Metastatic Kidney... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Halozyme and Incyte Partner to Advance Subcutaneous INCA033989 for mutCALR-... Read Post »
Clinical Trials Mergers & AcquisitionsBayer Partners with Henry Ford Health to Expand Clinical Trials Bayer Partners with Henry Ford Health to Expand Clinical Trials Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and argenx Partner to Accelerate AI-Driven De Novo Antibody ... Chai Discovery and argenx Partner to Accelerate AI-Driven De Novo Antibody ... Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires AtaiBeckley to Advance BPL-003 for Treatment-Resistant Depre... Lilly Acquires AtaiBeckley to Advance BPL-003 for Treatment-Resistant Depre... Read Post »
Health Tidings Mergers & AcquisitionsNovartis Partners With Chai Discovery to Advance AI Antibody Discovery Novartis Partners With Chai Discovery to Advance AI Antibody Discovery Read Post »
Health Tidings Mergers & AcquisitionsSpero Secures Global Rights to Innovent’s Anti-CD40L Antibody IBI355 in U... Spero Secures Global Rights to Innovent’s Anti-CD40L Antibody IBI355 in U... Read Post »
Health Tidings Mergers & AcquisitionsAstraZeneca Licenses Zegfrovy from Dizal in Up to $1.5 Billion Deal to Expa... AstraZeneca Licenses Zegfrovy from Dizal in Up to $1.5 Billion Deal to Expa... Read Post »
